Statistik Asas
| CIK | 1859035 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Mountain Crest Acquisition Corp. V - Equity Right
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 1, 2025 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (C |
|
| August 7, 2025 |
Exhibit 16.1 August 7, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K filed with the U.S. Securities and Exchange Commission on August 7, 2025 of Mountain Crest Acquisition Corp. V (the “Company”) and agree with the statements relating only to UHY LLP contained therein. We have no basis to agree or disagree w |
|
| May 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41497 CUSIP NUMBER 27877D104 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi |
|
| April 28, 2025 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 25, 2025 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (C |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP |
|
| April 1, 2025 |
Exhibit 19.1 Mountain Crest Acquisition Corp. V Insider Trading Policy TABLE OF CONTENTS Page PART I 1 1. Applicability 1 2. General Policy: No Trading or Causing Trading While in Possession of Material Nonpublic Information 2 3. Definitions 2 4. Violations of Insider Trading Rules and Regulations 4 PART II 5 1. Blackout Periods 5 2. Trading Window 6 3. Pre-Clearance of Securities Transactions 6 4 |
|
| April 1, 2025 |
Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended ( |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-41062 NOTIFICATION OF LATE FILING CUSIP NUMBER 62404B107 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra |
|
| February 14, 2025 |
EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement is being jointly filed, and all amendments thereto will be jointly filed, by Mountain Crest Global Holdings LLC, as the main and designated filer, on behalf of each of the persons and entities named below that is named as a reporting person in such filing. |
|
| December 6, 2024 |
MCAG / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment SC 13G/A 1 meteoramcag113024a3.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* MOUNTAIN CREST ACQUISITION CORP. V (Name of Issuer) Common Stock (Title of Class of Securities) 62404B107 (CUSIP Number) November 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| November 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 14, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST AC |
|
| November 14, 2024 |
MCAG / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment SC 13G/A 1 meteoramcag093024a2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* MOUNTAIN CREST ACQUISITION CORP. V (Name of Issuer) Common Stock (Title of Class of Securities) 62404B107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 8, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) |
|
| November 12, 2024 |
Exhibit 3.1 AMENDMENT NO. 4 TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V November 8, 2024 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The original certifica |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 30, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) |
|
| October 22, 2024 |
MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 October 22, 2024 Via EDGAR Division of Corporation Finance Office of Real Estate a& Construction U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Isabel Rivera Dorrie Yale Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Schedule 14A Submitted October 21, 2024 |
|
| October 22, 2024 |
PRER14A 1 mountaincrest5prer14a.htm PRER14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 2 to SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriat |
|
| October 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| October 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 to SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confi |
|
| October 21, 2024 |
MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 October 21, 2024 Via EDGAR Division of Corporation Finance Office of Real Estate a& Construction U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Isabel Rivera Dorrie Yale Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Schedule 14A Submitted October 10, 2024 |
|
| October 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI |
|
| September 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 13, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation |
|
| September 18, 2024 |
Exhibit 99.1 Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance New York, New York – September 18, 2024 – Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the st |
|
| September 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS |
|
| September 12, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 11, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation |
|
| August 30, 2024 |
CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED Exhibit 99.1 CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED NEW YORK, USA and SEOUL, Korea, August 29, 2024 (GLOBE NEWSWIRE) - Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with its common stock publicly traded on The Nasdaq Stock Market under the trading symbol “MCA |
|
| August 30, 2024 |
Exhibit 2.1 EXECUTION VERSION BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V and CUBEBIO CO. LTD, dated as of August 29, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 3 1.1 Defined Terms 3 ARTICLE II THE SPAC MERGER AND THE SHARE SWAP 19 2.1 Transactions 19 2.2 Merger Effective Time 20 2.3 Closing 21 ARTICLE III CLOSING TRANSACTIONS 21 3.1 Effect of Merger on |
|
| August 30, 2024 |
Exhibit 2.1 EXECUTION VERSION BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V and CUBEBIO CO. LTD, dated as of August 29, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 3 1.1 Defined Terms 3 ARTICLE II THE SPAC MERGER AND THE SHARE SWAP 19 2.1 Transactions 19 2.2 Merger Effective Time 20 2.3 Closing 21 ARTICLE III CLOSING TRANSACTIONS 21 3.1 Effect of Merger on |
|
| August 30, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 30, 2024 |
Exhibit 10.2 COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Company Shareholder”), Mountain Crest Acquisition Corp., V, a Delaware corporation (“SPAC”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the |
|
| August 30, 2024 |
Exhibit 10.1 SPONSOR SUPPORT AGREEMENT This SPONSOR SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among Mountain Crest Global Holdings LLC, a Delaware limited liability company (the “Sponsor”), shareholders listed on Exhibit A hereto (each a “Stockholder”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the laws of Korea (th |
|
| August 30, 2024 |
Exhibit 10.1 SPONSOR SUPPORT AGREEMENT This SPONSOR SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among Mountain Crest Global Holdings LLC, a Delaware limited liability company (the “Sponsor”), shareholders listed on Exhibit A hereto (each a “Stockholder”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the laws of Korea (th |
|
| August 30, 2024 |
CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED Exhibit 99.1 CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED NEW YORK, USA and SEOUL, Korea, August 29, 2024 (GLOBE NEWSWIRE) - Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with its common stock publicly traded on The Nasdaq Stock Market under the trading symbol “MCA |
|
| August 30, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 30, 2024 |
Exhibit 10.2 COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Company Shareholder”), Mountain Crest Acquisition Corp., V, a Delaware corporation (“SPAC”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the |
|
| August 26, 2024 |
Exhibit 99.7 MOUNTAIN CREST ACQUISITION CORP. V CLAWBACK POLICY Introduction The Board of Directors (the “Board”) of Mountain Crest Acquisition Corp. V (the “Company”) believes that it is in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosoph |
|
| August 26, 2024 |
Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended ( |
|
| August 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP |
|
| August 15, 2024 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| August 15, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 14, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit |
|
| July 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Co |
|
| July 24, 2024 |
Exhibit 99.1 Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q New York, New York – July 24, 2024 – Mountain Crest Acquisition Corp. V (NASDAQ: MCAG, the “Company”) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staf |
|
| June 7, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 5, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Com |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi |
|
| May 2, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 2, 2024 |
Exhibit 99.1 CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V New York, USA and Seoul, Korea – May 2, 2024 – Mountain Crest Acquisition Corp. V, a Delaware corporation (“Mountain Crest V”), that is a Nasdaq-listed (Nasdaq: MCAG) special purpose acquisition company (“SPAC”), and CUBEBIO Co., Ltd., a Korea-based company (“CUBEB |
|
| May 2, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 2, 2024 |
Exhibit 99.1 CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V New York, USA and Seoul, Korea – May 2, 2024 – Mountain Crest Acquisition Corp. V, a Delaware corporation (“Mountain Crest V”), that is a Nasdaq-listed (Nasdaq: MCAG) special purpose acquisition company (“SPAC”), and CUBEBIO Co., Ltd., a Korea-based company (“CUBEB |
|
| May 1, 2024 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| May 1, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 30, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File |
|
| April 24, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File |
|
| April 24, 2024 |
Exhibit 10.1 NOTE CONVERSION AGREEMENT This NOTE CONVERSION AGREEMENT (this “Agreement”) is made as of April 19, 2024 by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Mountain Crest Global Holdings LLC, a Delaware limited liability company and the Company’s sponsor (the “Holder”). R E C I T A L S WHEREAS, the Company issued the Holder a non-interest be |
|
| April 3, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 3, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File |
|
| April 3, 2024 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-41062 NOTIFICATION OF LATE FILING CUSIP NUMBER 62404B107 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra |
|
| February 14, 2024 |
US62404B1070 / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment SC 13G/A 1 meteoramcag123123a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* MOUNTAIN CREST ACQUISITION CORP. V (Name of Issuer) Common Stock (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| February 14, 2024 |
SC 13G/A 1 mountaincrestsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1)* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 per Share (T |
|
| February 5, 2024 |
SC 13G/A 1 p24-0522sc13ga.htm MOUNTAIN CREST ACQUISITION CORP. V SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of thi |
|
| December 19, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 13, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST AC |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| November 13, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 9, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 1, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| November 1, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 26, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 23, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 26, 2023 |
Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market Exhibit 99.1 Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) - Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its securities from the Nasdaq Global Market to the Nasdaq Capital Market. |
|
| September 19, 2023 |
Exhibit 10.3 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i |
|
| September 19, 2023 |
Exhibit 10.2 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i |
|
| September 19, 2023 |
Exhibit 10.5 NOTE CONVERSION AGREEMENT This NOTE CONVERSION AGREEMENT (this “Agreement”) is made as of September 13, 2023 by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Mountain Crest Global Holdings, LLC, a Delaware limited liability company (the “Holder”). R E C I T A L S WHEREAS, the Company issued the Holder a non-interest bearing promissory note |
|
| September 19, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 13, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission |
|
| September 19, 2023 |
Exhibit 10.1 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i |
|
| September 19, 2023 |
Exhibit 10.4 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i |
|
| August 22, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 21, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 21, 2023 |
Exhibit 3.1 Charter Amendment AMENDMENT NO. 3 TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V August 21, 2023 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The o |
|
| August 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI |
|
| August 21, 2023 |
Exhibit 10.1 AMENDMENT TO PROMISSORY NOTE THIS AMENDMENT TO PROMISSORY NOTE (this “Agreement”), dated as of May 16, 2023, by and between Mountain Crest Acquisition Corp. V, a Delaware corporation and blank check company (the “Maker”), and Mountain Crest Global Holdings LLC (the “Payee”). WHEREAS, Maker executed and delivered a Promissory Note dated as of February 15, 2023 (the “Note”) for the bene |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| July 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confid |
|
| July 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co |
|
| June 20, 2023 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co |
|
| June 14, 2023 |
Filed by AUM Biosciences Limited. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Mountain Crest Acquisition Corp. V Commission File No.: 001-41062 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com |
|
| June 12, 2023 |
US62404B1070 / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| May 22, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 18, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS |
|
| May 12, 2023 |
Exhibit 3.1 SECOND AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V May 12, 2023 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The original certificate |
|
| May 12, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 12, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 12, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 12, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 12, 2023 |
Exhibit 3.1 SECOND AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V May 12, 2023 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The original certificate |
|
| May 11, 2023 |
Filed by AUM Biosciences Limited. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Mountain Crest Acquisition Corp. V Commission File No.: 001-41062 INVESTOR PRESENTATION May 2023 (Corrected Version) This presentation is provided for informational purposes only and has been prepared to assist i |
|
| May 11, 2023 |
Exhibit 99.1 INVESTOR PRESENTATION May 2023 (Corrected Version) This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the “proposed business combination”) among (i) AUM Bioscienc es Limited (“Holdco”), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) AUM Bios |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com |
|
| May 10, 2023 |
Exhibit 99.1 INVESTOR PRESENTATION May 2023 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the “proposed business combination”) among (i) AUM Bioscienc es Limited (“Holdco”), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) AUM Biosciences Delaware Mer |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com |
|
| May 10, 2023 |
Filed by AUM Biosciences Limited. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Mountain Crest Acquisition Corp. V Commission File No.: 001-41062 INVESTOR PRESENTATION May 2023 This presentation is provided for informational purposes only and has been prepared to assist interested parties in |
|
| April 27, 2023 |
AUM Biosciences to Participate in Inaugural EF Hutton Global Conference Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences to Participate in Inaugural EF Hutton Global Conference Singapore and Bethesda, MD, April 26, 2023 - AUM Biosciences Pte. |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| April 26, 2023 |
345 Park Avenue New York, NY 10154-1895 Direct Main Fax 212.407.4000 212.407.4000 212.407.4990 April 26, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attn: Isabel Rivera Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Form PRE14A Filed April 14, 2023 File No |
|
| April 25, 2023 |
345 Park Avenue New York, NY 10154-1895 Direct Main Fax 212.407.4000 212.407.4000 212.407.4990 April 25, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attn: Isabel Rivera Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Form PRE14A Filed April 14, 2023 File No |
|
| April 19, 2023 |
Exhibit 2.1 AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT (this “Amendment No. 3”) is made as of April 19, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private compa |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C |
|
| April 19, 2023 |
Exhibit 2.1 AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT (this “Amendment No. 3”) is made as of April 19, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private compa |
|
| April 19, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| April 7, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 3, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co |
|
| March 31, 2023 |
Exhibit 10.2 PROMISSORY NOTE Principal Amount: $108,001.90 Date: March 31, 2023 New York, New York On demand, for valuable consideration given to Mountain Crest Acquisition Corp. V (hereinafter “Maker”), Maker does hereby promise to pay to UHY Advisors/UHY LLP, (hereinafter “Holder”), at 1185 Avenue of the Americas, 38th Floor, New York, NY 10036, the principal sum of One Hundred Eight Thousand On |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP |
|
| March 31, 2023 |
Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended ( |
|
| March 30, 2023 |
Exhibit 2.1 AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT (this “Amendment #2”) is made as of March 30, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limite |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C |
|
| March 30, 2023 |
Exhibit 2.1 AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT (this “Amendment #2”) is made as of March 30, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limite |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C |
|
| February 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| February 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| February 16, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| February 16, 2023 |
EX-10.1 2 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACT |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * Mountain Crest Acquisition Corp. V (Name of Issuer) Common (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| February 13, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| February 13, 2023 |
US62404B1070 / Mountain Crest Acquisition Corp. V / Beryl Capital Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| February 13, 2023 |
Exhibit 2.1 AMENDMENT TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT TO BUSINESS COMBINATION AGREEMENT (this “Amendment”) is made as of February 10, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limited by s |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| February 13, 2023 |
SC 13G/A 1 d400625dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp V (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Sta |
|
| February 13, 2023 |
Exhibit 2.1 AMENDMENT TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT TO BUSINESS COMBINATION AGREEMENT (this “Amendment”) is made as of February 10, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limited by s |
|
| February 9, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| January 30, 2023 |
Exhibit 2.1 JOINDER AGREEMENT This JOINDER AGREEMENT, dated as of January 27, 2023 (this “Joinder Agreement”), to the Business Combination Agreement (as the same may be amended, restated, supplemented or modified from time to time in accordance with the terms hereof, the “Business Combination Agreement”), dated as of October 19, 2022, by and between Mountain Crest Acquisition Corp. V, a Delaware c |
|
| January 30, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| January 30, 2023 |
425 1 mountaincrestv425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other |
|
| January 30, 2023 |
EX-2.1 2 mountaincrestvex2-1.htm EXHIBIT 2.1 Exhibit 2.1 JOINDER AGREEMENT This JOINDER AGREEMENT, dated as of January 27, 2023 (this “Joinder Agreement”), to the Business Combination Agreement (as the same may be amended, restated, supplemented or modified from time to time in accordance with the terms hereof, the “Business Combination Agreement”), dated as of October 19, 2022, by and between Mou |
|
| January 5, 2023 |
Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma AUM302 is potentially elig |
|
| December 21, 2022 |
Exhibit 3.1 2 3 |
|
| December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| December 21, 2022 |
Exhibit 10.1 AMENDMENT TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT This Amendment No. 1 (this ?Amendment?), dated as of December 20, 2022, to the Investment Management Trust Agreement (as defined below) is made by and between Mountain Crest Acquisition Corp. V (the ?Company?) and Continental Stock Transfer & Trust Company, as trustee (?Trustee?). All terms used but not defined herein shall have t |
|
| December 21, 2022 |
EX-10.1 3 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 AMENDMENT TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT This Amendment No. 1 (this “Amendment”), dated as of December 20, 2022, to the Investment Management Trust Agreement (as defined below) is made by and between Mountain Crest Acquisition Corp. V (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). Al |
|
| December 21, 2022 |
Exhibit 3.1 2 3 |
|
| December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| December 19, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| December 6, 2022 |
DEF 14A 1 mountaincrest5def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary |
|
| November 30, 2022 |
AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma AUM302 has potential to be the first m |
|
| November 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us |
|
| November 16, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 16, 2022 |
425 1 mountaincrest5425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or othe |
|
| November 16, 2022 |
INVESTOR PRESENTATION NOVEMBER 2022 Exhibit 99.1 INVESTOR PRESENTATION NOVEMBER 2022 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the ? proposed business combination ? ) among (i) AUM Biosciences Limited ( ? Holdco ? ), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) a to be formed De |
|
| November 16, 2022 |
INVESTOR PRESENTATION NOVEMBER 2022 Exhibit 99.1 INVESTOR PRESENTATION NOVEMBER 2022 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the ? proposed business combination ? ) among (i) AUM Biosciences Limited ( ? Holdco ? ), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) a to be formed De |
|
| November 15, 2022 |
425 1 mountaincrestv425.htm 425 Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST AC |
|
| November 4, 2022 |
AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit SINGAPORE and BETHESDA, Md., Nov. 04, 2022 (GLOBE NEWSWI |
|
| October 20, 2022 |
Form of Amended and Restated Registration Rights Agreement. Exhibit 10.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2022, is made and entered into by and among [ ], a Cayman Islands exempted company (the “Company”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 201810204D (“AUM”), |
|
| October 20, 2022 |
Exhibit 10.2 Execution Version SPAC STOCKHOLDER SUPPORT AGREEMENT This SPAC STOCKHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this ?Agreement?), is entered into by and among the stockholders listed on Exhibit A hereto (each, a ?Stockholder?), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 201810204D (the ?Compan |
|
| October 20, 2022 |
EX-10.2 4 mountaincrest5ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Execution Version SPAC STOCKHOLDER SUPPORT AGREEMENT This SPAC STOCKHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this “Agreement”), is entered into by and among the stockholders listed on Exhibit A hereto (each, a “Stockholder”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with com |
|
| October 20, 2022 |
Business Combination Agreement, dated as of October 19, 2022, by and between SPAC and the Company. EX-2.1 2 mountaincrest5ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 Execution Version BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V, and AUM BIOSCIENCES PTE. LTD. dated as of October 19, 2022 *Certain exhibits and the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of any om |
|
| October 20, 2022 |
Exhibit 99.1 AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V ? The transaction reflects a pre-money equity value of $400 million for AUM Biosciences ? Transaction is expected to provide $69 million of gross proceeds (assuming no redemptions by Mountain Crest sto |
|
| October 20, 2022 |
EX-10.3 5 mountaincrest5ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of , 2022, by and among the undersigned (the “Holder”), [ ], a Cayman Islands exempted company (“Holdco”) and Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”). Capitalized terms used and not otherwise defined herein shall have the meanings given su |
|
| October 20, 2022 |
EX-10.1 3 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Shareholder”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singa |
|
| October 20, 2022 |
EX-10.1 3 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Shareholder”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singa |
|
| October 20, 2022 |
Form of Amended and Restated Registration Rights Agreement. EX-10.4 6 mountaincrest5ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2022, is made and entered into by and among [ ], a Cayman Islands exempted company (the “Company”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with |
|
| October 20, 2022 |
EX-10.3 5 mountaincrest5ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of , 2022, by and among the undersigned (the “Holder”), [ ], a Cayman Islands exempted company (“Holdco”) and Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”). Capitalized terms used and not otherwise defined herein shall have the meanings given su |
|
| October 20, 2022 |
425 1 mountaincrest5425.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other |
|
| October 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| October 20, 2022 |
Business Combination Agreement, dated as of October 19, 2022, by and between SPAC and the Company. Exhibit 2.1 Execution Version BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V, and AUM BIOSCIENCES PTE. LTD. dated as of October 19, 2022 *Certain exhibits and the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its |
|
| October 20, 2022 |
EX-99.1 7 mountaincrest5ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V · The transaction reflects a pre-money equity value of $400 million for AUM Biosciences · Transaction is expected to provide $69 million of gross proceed |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP |
|
| March 31, 2022 |
EX-4.5 2 mountaincrestex4-5.htm EXHIBIT 4.5 Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2021, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the S |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ?240.13d-2 Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 per Share (Title of Class of Securities) 62404B 107 (CUSIP |
|
| February 14, 2022 |
MCAG / Mountain Crest Acquisition Corp V / PERISCOPE CAPITAL INC. - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp V (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to des |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * Mountain Crest Acquisition Corp. V (Name of Issuer) Common (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 11, 2022 |
MCAG / Mountain Crest Acquisition Corp V / Beryl Capital Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| February 7, 2022 |
SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A AMENDMENT NO. 1 INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Da |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41062 MOUNTAIN CRE |
|
| December 17, 2021 |
Saba Capital Management, L.P. - FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 7, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 24, 2021 |
Mountain Crest Acquisition Corp. V BALANCE SHEET Exhibit 99.1 Mountain Crest Acquisition Corp. V BALANCE SHEET November 16, Pro Forma Adjustments As Adjusted 2021 (unaudited) (unaudited) ASSETS CURRENT ASSETS Cash $ 610,839 $ - $ 610,839 Prepaid expenses 29,200 - 29,200 Cash held in Trust 60,000,000 9,000,000 (a) 69,000,000 180,000 (b) (180,000 )(c) Total current assets 60,640,039 9,000,000 69,640,039 TOTAL ASSETS $ 60,640,039 $ 9,000,000 $ 69,6 |
|
| November 24, 2021 |
Other Events, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 18, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 22, 2021 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 22, 2021 |
MOUNTAIN CREST ACQUISITION CORP. V INDEX TO FINANCIAL STATEMENT Exhibit 99.1 MOUNTAIN CREST ACQUISITION CORP. V INDEX TO FINANCIAL STATEMENT Page Financial Statement: Report of Independent Registered Public Accounting Firm F-1 Balance Sheet as of November 16, 2021 F-2 Notes to Financial Statement F-3 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Mountain Crest Acquisition Corp. V Opinion |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 62404B2061 (CUSIP Number) November 12, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| November 19, 2021 |
Space Summit Capital LLC - SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Units (Title of Class of Securities) 62404B206 (CUSIP Number) November 12, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| November 18, 2021 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of November, 2021, by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”) and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Investors an |
|
| November 18, 2021 |
Exhibit 4.1 RIGHTS AGREEMENT This Rights Agreement (this “Agreement”) is made as of November 12, 2021 between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New York 10004 (the “Right Agent”). WHEREAS, the Company has received a firm commitment from Chardan |
|
| November 18, 2021 |
Exhibit 1.1 6,000,000 Units Mountain Crest Acquisition Corp. V UNDERWRITING AGREEMENT November 12, 2021 Chardan Capital Markets, LLC 17 State Street, 21st Floor New York, New York 10004 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Mountain Crest Acquisition Corp. V, a Delaware corporation (“Company”), hereby confirms its agreement with Cha |
|
| November 18, 2021 |
Exhibit 10.3 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT, dated as of November 12, 2021 (?Agreement?), by and among MOUNTAIN CREST ACQUISITION CORP. V, a Delaware corporation (?Company?), and the initial shareholders listed on the signature pages hereto (collectively, the ?Initial Shareholders?) CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (?Escrow Agent?). WHEREAS, th |
|
| November 18, 2021 |
MMCAP International Inc. SPC - NONE Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 62404B206 (CUSIP Number) November 16, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| November 18, 2021 |
Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made as of November [●], 2021 by and between Mountain Crest Acquisition Corp. V (the “Company”) and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, No. 333-260124 (“Registration Statement”) |
|
| November 18, 2021 |
Amended and Restated Certificate of Incorporation. Exhibit 3.1 |
|
| November 18, 2021 |
Exhibit 10.6 November [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: Mountain Crest Acquisition Corp. V (the ?Company?), a blank check company formed for the purpose of acquiring one or more businesses or entities (a ?Business Combination?), intends to register its securities under the Securities Act of 1933, as amended (?Secu |
|
| November 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 12, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) |
|
| November 18, 2021 |
Exhibit 10.5 FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of November [?], 2021, by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the ?Company?), and the undersigned directors and officers of the Company (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly held corporations as directo |
|
| November 18, 2021 |
Exhibit 10.7 MOUNTAIN CREST ACQUISITION CORP. V 311 West 43rd Street, 12th Floor New York, NY 10036 [], 2021 Mountain Crest Global Holdings LLC 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the effective date (the ?Effective Date?) of the registration statement (the ?Registration Statement?) for the initial publ |
|
| November 18, 2021 |
Exhibit 10.1 November [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, NY 10004 Re: Initial Public Offering Gentlemen: This letter is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and between Mountain Crest Acquisit |
|
| November 15, 2021 |
$60,000,000 Mountain Crest Acquisition Corp. V 6,000,000 Units Prospectus Filed Pursuant to Rule 424(b)(4) Registration No. 333-260124 $60,000,000 Mountain Crest Acquisition Corp. V 6,000,000 Units Mountain Crest Acquisition Corp. V is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Mountain Crest Acquisition Corp. |
|
| November 9, 2021 |
Form of Registration Rights Agreement by and between the Registrant and Initial Stockholders. Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of [●], 2021, by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”) and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Investors and the |
|
| November 9, 2021 |
As filed with the Securities and Exchange Commission on November 8, 2021 As filed with the Securities and Exchange Commission on November 8, 2021 Registration No. |
|
| November 9, 2021 |
Form of Subscription Agreement between Registrant and Mountain Crest Global Holdings LLC. Exhibit 10.7 [●], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: Mountain Crest Acquisition Corp. V (the “Company”), a blank check company formed for the purpose of acquiring one or more businesses or entities (a “Business Combination”), intends to register its securities under the Securities Act of 1933, as amended (“Securities Ac |
|
| November 9, 2021 |
Exhibit 10.3 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT, dated as of , 2021 (?Agreement?), by and among MOUNTAIN CREST ACQUISITION CORP. V, a Delaware corporation (?Company?), and the initial shareholders listed on the signature pages hereto (collectively, the ?Initial Shareholders?) CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (?Escrow Agent?). WHEREAS, the Company h |
|
| November 9, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 6,000,000 Units Mountain Crest Acquisition Corp. V UNDERWRITING AGREEMENT , 2021 Chardan Capital Markets, LLC 17 State Street, 21st Floor New York, New York 10004 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Mountain Crest Acquisition Corp. V, a Delaware corporation (“Company”), hereby confirms its agreement with Chardan Cap |
|
| November 9, 2021 |
Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made as of [?], 2021 by and between Mountain Crest Acquisition Corp. V (the ?Company?) and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, No. 333-260124 (?Registration Statement?), for its |
|
| November 9, 2021 |
Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant. Exhibit 4.4 RIGHTS AGREEMENT This Rights Agreement (this “Agreement”) is made as of , 2021 between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New York 10004 (the “Right Agent”). WHEREAS, the Company has received a firm commitment from Chardan Capital Ma |
|
| October 7, 2021 |
EX-3.1 3 mountaincrest5ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V THE UNDERSIGNED, in order to form a corporation for the purposes herein stated, under and pursuant to the provisions of the General Corporation Law of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Mountain Crest Acquisition Corp. V |
|
| October 7, 2021 |
Exhibit 4.3 NUMBER MCAGR RIGHTS MOUNTAIN CREST ACQUISITION CORP. V INCORPORATED UNDER THE LAWS OF THE DELAWARE RIGHT SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 62404B 115 THIS CERTIFIES THAT, for value received is the registered holder of a right or rights (each, a “Right”) to automatically receive one-tenth of one share of common stock, $0.0001 par value (“Common Stock”), of Mountain Crest Acquisi |
|
| October 7, 2021 |
Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made as of [●], 2021 by and between Mountain Crest Acquisition Corp. V (the “Company”) and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, No. 333-[●] (“Registration Statement”), for its in |
|
| October 7, 2021 |
Specimen Common Stock Certificate. Exhibit 4.1 NUMBER MCAGU UNITS MOUNTAIN CREST ACQUISITION CORP. V SEE?REVERSE?FOR CERTAIN DEFINITIONS CUSIP 62404B 206 UNITS CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE RIGHT TO RECEIVE ONE-TENTH OF ONE SHARE OF COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (?Unit?) consists of one (1) share of common stock, par value $0.0001 per share (?Common Stock?), of Mountain Crest Ac |
|
| October 7, 2021 |
Exhibit 10.6 MOUNTAIN CREST ACQUISITION CORP. V 311 West 43rd Street, 12th Floor New York, NY 10036 [], 2021 Mountain Crest Global Holdings LLC 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration Statement”) for the initial publ |
|
| October 7, 2021 |
Exhibit 10.3 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT, dated as of , 2021 (“Agreement”), by and among MOUNTAIN CREST ACQUISITION CORP. V, a Delaware corporation (“Company”), and the initial shareholders listed on the signature pages hereto (collectively, the “Initial Shareholders”) CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (“Escrow Agent”). WHEREAS, the Company h |
|
| October 7, 2021 |
Form of Registration Rights Agreement by and between the Registrant and Initial Stockholders. Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of [●], 2021, by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”) and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Investors and the |
|
| October 7, 2021 |
Power of Attorney (included on the signature page of the original filing hereof). As filed with the Securities and Exchange Commission on October 7, 2021 Registration No. |
|
| October 7, 2021 |
EX-14 18 mountaincrest5ex14.htm EXHIBIT 14 Exhibit 14 CODE OF ETHICS 1. Introduction The Board of Directors of Mountain Crest Acquisition Corp. V has adopted this code of ethics (this “Code”), which is applicable to all directors, officers and employees, to: ● promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and profess |
|
| October 7, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 5,000,000 Units Mountain Crest Acquisition Corp. V UNDERWRITING AGREEMENT , 2021 Chardan Capital Markets, LLC 17 State Street, 21st Floor New York, New York 10004 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Mountain Crest Acquisition Corp. V, a Delaware corporation (“Company”), hereby confirms its agreement with Chardan Cap |
|
| October 7, 2021 |
Form of Subscription Agreement between Registrant and Mountain Crest Global Holdings LLC. Exhibit 10.7 [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: Mountain Crest Acquisition Corp. V (the ?Company?), a blank check company formed for the purpose of acquiring one or more businesses or entities (a ?Business Combination?), intends to register its securities under the Securities Act of 1933, as amended (?Securities Ac |
|
| October 7, 2021 |
EX-10.5 15 mountaincrest5ex10-5.htm EXHIBIT 10.5 Exhibit 10.5 FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of , 2021, by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly held corporations as directors, officers or i |
|
| October 7, 2021 |
Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant. EX-4.4 9 mountaincrest5ex4-4.htm EXHIBIT 4.4 Exhibit 4.4 RIGHTS AGREEMENT This Rights Agreement (this “Agreement”) is made as of , 2021 between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New York 10004 (the “Right Agent”). WHEREAS, the Company has recei |
|
| October 7, 2021 |
Specimen Common Stock Certificate. Exhibit 4.2 NUMBER MCAG SHARES MOUNTAIN CREST ACQUISITION CORP. V INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK SEE REVERSE FOR CERTAIN DEFINITIONS This Certifies that CUSIP 62404B 107 is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE COMMON STOCK OF MOUNTAIN CREST ACQUISITION CORP. V transferable on the books of |
|
| October 7, 2021 |
Form of Insider Letter Agreement among the Registrant and the Registrant’s Officers and Directors. Exhibit 10.1 [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, NY 10004 Re: Initial Public Offering Gentlemen: This letter is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and between Mountain Crest Acquisition Corp. |
|
| October 7, 2021 |
Form of Amended and Restated Certificate of Incorporation. Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Sections 242 and 245 of the Delaware General Corporation Law Mountain Crest Acquisition Corp. V, a corporation existing under the laws of the State of Delaware (the “Corporation”), by its Chief Executive Officer, hereby certifies as follows: 1. The name of the Corporation is “Mountain Cr |
|
| October 7, 2021 |
EX-3.3 5 mountaincrest5ex3-3.htm EXHIBIT 3.3 Exhibit 3.3 BYLAWS OF MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - BY-LAWS OF MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I OFFICES SECTION 1. Principal Office. The registered office of the corporation shall be located in such place as may be provided from time to time in the Certificate of Incorporation. SECTION 2. Other Offices. The co |
|
| October 7, 2021 |
Form of Compensation Committee Charter. Exhibit 99.2 COMPENSATION COMMITTEE CHARTER OF MOUNTAIN CREST ACQUISITION CORP. V Adopted: [], 2021 The responsibilities and powers of the Compensation Committee of the Board of Directors (the “Board”) of Mountain Crest Acquisition Corp. V (the “Company”), as delegated by the Board, are set forth in this charter (this “Charter”). Whenever the Compensation Committee takes an action, it shall exerci |
|
| October 7, 2021 |
Form of Audit Committee Charter. Exhibit 99.1 AUDIT COMMITTEE CHARTER OF MOUNTAIN CREST ACQUISITION CORP. V Adopted: [], 2021 The responsibilities and powers of the Audit Committee of the Board of Directors (the ?Board?) of Mountain Crest Acquisition Corp. V (the ?Company?), as delegated by the Board, are set forth in this charter (this ?Charter?). Whenever the Audit Committee takes an action, it shall exercise its independent ju |
|
| September 9, 2021 |
CERTIFICATE OF INCORPORATION MOUNTAIN CREST ACQUISITION CORP. V Exhibit 3.1 CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V THE UNDERSIGNED, in order to form a corporation for the purposes herein stated, under and pursuant to the provisions of the General Corporation Law of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Mountain Crest Acquisition Corp. V (hereinafter called the “Corporation”). SECON |
|
| September 9, 2021 |
Confidentially submitted to the Securities and Exchange Commission on September 8, 2021 This draft registration statement has not been publicly filed with the U. |
|
| September 9, 2021 |
EX-3.3 3 filename3.htm Exhibit 3.3 BYLAWS OF MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - BY-LAWS OF MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I OFFICES SECTION 1. Principal Office. The registered office of the corporation shall be located in such place as may be provided from time to time in the Certificate of Incorporation. SECTION 2. Other Offices. The corporation may also hav |
|
| June 14, 2021 |
DRS 1 filename1.htm Confidentially submitted to the Securities and Exchange Commission on June 11, 2021 This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UN |
|
| June 14, 2021 |
CERTIFICATE OF INCORPORATION MOUNTAIN CREST ACQUISITION CORP. V Exhibit 3.1 CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V THE UNDERSIGNED, in order to form a corporation for the purposes herein stated, under and pursuant to the provisions of the General Corporation Law of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Mountain Crest Acquisition Corp. V (hereinafter called the “Corporation”). SECON |
|
| June 14, 2021 |
EX-3.3 3 filename3.htm Exhibit 3.3 BYLAWS OF MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - BY-LAWS OF MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I OFFICES SECTION 1. Principal Office. The registered office of the corporation shall be located in such place as may be provided from time to time in the Certificate of Incorporation. SECTION 2. Other Offices. The corporation may also hav |
